TY  - JOUR
ID  - arxiv98131
EP  - 5
UR  - https://universalconference.us/index.php/isirc/article/view/1533
N2  - Emerging markets represent an exceptional opportunity for the pharmaceutical industry. Although a precise definition is not yet available, economists define emerging markets as developing prosperous countries in which investment is expected to result in higher income despite high risks. Qualifying a market as emerging is not merely based on the economic status of the country, but also on several criteria that render the definition applicable to each country.
IS  - 3
KW  - Emerging Markets
KW  -  Developed Markets
KW  -  Pharmaceutical Companies
KW  -   Drugs and Disease
KW  -  BRICS
KW  -  MIST
JF  - INTERNATIONAL SCIENTIFIC INNOVATION RESEARCH CONFERENCE
TI  - Current relevance of pharmaceutical economy
AV  - public
Y1  - 2024/05/24/
A1  - Kh. O. Darmanov, Kh. O. Darmanov
VL  - 1
SP  - 3
ER  -